(Q46599077)

23 December 2017

title

Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment (English)

1 reference

23 December 2017

author name string

Stergianou K

series ordinal

1

1 reference

23 December 2017

Fox C

series ordinal

2

1 reference

23 December 2017

Russell NH

series ordinal

3

1 reference

23 December 2017

publication date

1 September 2005

1 reference

23 December 2017

published in

Leukemia

1 reference

23 December 2017

volume

19

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

page(s)

1680-1681

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403877

exact match

0 references

cites work

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403877

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403877

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403877

Amplification of the ABL gene in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403877

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2403877

1 reference

23 December 2017

1 reference

23 December 2017